US Brand Name(s): Venclexta
Use of Venetoclax in Cancer Treatment
Venetoclax has authorization to treat the following conditions:
Experts have discovered Acute myeloid leukemia only recently. People aged 75 and above, as well as adults who the doctors cannot treat with intense induction chemotherapy, are candidates for this treatment. They use Azacitidine, decitabine, or low-dose cytarabine to treat it.
Adults with CLL or SLL (chronic lymphocytic leukemia/small lymphocytic lymphoma/small lymphocytic lymphoma/small lymphocytic lymphoma/small lymphocytic lymphoma/small lymphocy It can be administered on its own or in combination with obinutuzumab or rituximab.
Researchers are also researching Venetoclax for use in the treatment of other cancers.
Detailed scientific definition- Definition from the NCI Drug Dictionary
Venetoclax Information on MedlinePlus – A summary of key information regarding this medication in layman’s terms, which may contain the following:
Cautions about this medicine; what are its uses and how to use it; what you should tell your doctor before taking it; things you should know about it before using it; other drugs that might interact with it; and possible negative effects.
Experts frequently investigate drugs to see whether they can treat or prevent conditions other than those with authorization. This patient information leaflet only covers authorized uses of the medications. However, much of the material might also apply to authorized uses under investigation.
